FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1254795002: Substance withdrawal syndrome (disorder)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Oct 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5143477019 Substance withdrawal syndrome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5143478012 Substance withdrawal en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5143479016 Substance withdrawal syndrome (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5143583018 Withdrawal syndrome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance withdrawal Is a Sequelae of disorders (disorder) true Inferred relationship Some
Substance withdrawal Due to The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months. false Inferred relationship Some 2
Substance withdrawal After The inability to regulate the use of a specified substance due to repeated or continuous use. Key features include a strong internal drive to use the substance, impaired control over use, prioritizing use over other activities, and continued use despite harm or negative consequences. This often comes with urges or cravings. Physiological dependence may also occur, marked by tolerance, withdrawal symptoms, or use of the substance to prevent withdrawal. These features typically appear over 12 months but can be diagnosed if use is continuous for at least 3 months. false Inferred relationship Some 1
Substance withdrawal After Disease true Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Withdrawal arrhythmia Due to True Substance withdrawal Inferred relationship Some 2
Substance use treatment: drug withdrawal (regime/therapy) Has focus True Substance withdrawal Inferred relationship Some 1
Delirium due to substance withdrawal syndrome (disorder) Due to True Substance withdrawal Inferred relationship Some 2
Tremor due to substance withdrawal (finding) Due to True Substance withdrawal Inferred relationship Some 1
Monitoring substance withdrawal Has focus True Substance withdrawal Inferred relationship Some 1
Seizure co-occurrent and due to substance withdrawal Due to True Substance withdrawal Inferred relationship Some 2
Buprenorphine and/or naloxone withdrawal Is a True Substance withdrawal Inferred relationship Some
Barbiturate withdrawal Is a True Substance withdrawal Inferred relationship Some
Ergotamine withdrawal Is a True Substance withdrawal Inferred relationship Some
Volatile inhalant withdrawal (disorder) Is a True Substance withdrawal Inferred relationship Some
Psychoactive substance withdrawal Is a True Substance withdrawal Inferred relationship Some
Opioid withdrawal Is a True Substance withdrawal Inferred relationship Some
Recreational drug misuse withdrawal (disorder) Is a True Substance withdrawal Inferred relationship Some
Steroidabstinenssyndrom Is a False Substance withdrawal Inferred relationship Some
A characteristic ruxolitinib discontinuation syndrome includes an acute relapse of disease symptoms, splenomegaly, and occasional hemodynamic decompensation. Symptoms can appear from less than 24 hours to up to 3 weeks after the abrupt discontinuation of ruxolitinib. Is a True Substance withdrawal Inferred relationship Some
Disorder of autonomic nervous system due to substance withdrawal syndrome (disorder) Due to True Substance withdrawal Inferred relationship Some 2
Neonatal abstinence syndrome Is a True Substance withdrawal Inferred relationship Some
At increased risk of substance withdrawal syndrome (finding) This attribute specifies the realization of a function True Substance withdrawal Inferred relationship Some 2
Steroid hormone withdrawal syndrome following harmful pattern of use (disorder) Is a True Substance withdrawal Inferred relationship Some
Corticosteroid withdrawal syndrome following harmful pattern of use (disorder) Is a True Substance withdrawal Inferred relationship Some
Steroid hormone withdrawal syndrome following therapeutic use (disorder) Is a True Substance withdrawal Inferred relationship Some
Corticosteroid withdrawal syndrome following therapeutic use (disorder) Is a True Substance withdrawal Inferred relationship Some
A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome is usually mild, commences within 1 week of stopping treatment, resolves spontaneously within 3 weeks, and consists of diverse physical and psychological symptoms, the commonest being dizziness, nausea, lethargy and headache. SSRI reinstatement leads to resolution within 48 hours. Is a True Substance withdrawal Inferred relationship Some

This concept is not in any reference sets

Back to Start